BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 3766576)

  • 1. Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
    Wilson TD; Forde MD; Crain AV; Dombrowski LJ; Joyce MA
    Am J Hosp Pharm; 1986 Sep; 43(9):2218-20. PubMed ID: 3766576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
    Taormina D; Abdallah HY; Venkataramanan R; Logue L; Burckart GJ; Ptachcinski RJ; Todo S; Fung JJ; Starzl TE
    Am J Hosp Pharm; 1992 Jan; 49(1):119-22. PubMed ID: 1373936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
    Riley CM
    Am J Hosp Pharm; 1988 Oct; 45(10):2079-91. PubMed ID: 3228079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
    Ptachcinski RJ; Logue LW; Burckart GJ; Venkataramanan R
    Am J Hosp Pharm; 1986 Jan; 43(1):94-7. PubMed ID: 3953588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of milrinone and epinephrine, atropine sulfate, lidocaine hydrochloride, or morphine sulfate injection.
    Wilson TD; Forde MD
    Am J Hosp Pharm; 1990 Nov; 47(11):2504-7. PubMed ID: 2278262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
    Galante LJ; Stewart JT; Warren FW; Johnson SM; Duncan R
    Am J Hosp Pharm; 1990 Jul; 47(7):1580-4. PubMed ID: 2368751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections.
    Visor GC; Lin LH; Jackson SE; Winterle JS; Lee G; Kenley RA
    Am J Hosp Pharm; 1986 Nov; 43(11):2810-2. PubMed ID: 3492139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery system.
    Kowalski SR; Gourlay GK
    Am J Hosp Pharm; 1990 Jul; 47(7):1584-7. PubMed ID: 2368752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
    Cheung YW; Cradock JC; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1987 Jan; 44(1):124-30. PubMed ID: 3548341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of amphotericin B in four concentrations of dextrose injection.
    Wiest DB; Maish WA; Garner SS; el-Chaar GM
    Am J Hosp Pharm; 1991 Nov; 48(11):2430-3. PubMed ID: 1746578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
    Beijnen JH; van Gijn R
    J Parenter Sci Technol; 1993; 47(4):166-71. PubMed ID: 8410562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.
    Lam NP; Kennedy PE; Jarosinski PF; Gallelli JF
    Am J Hosp Pharm; 1991 Feb; 48(2):280-2. PubMed ID: 2003500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
    Patel JP; Tran LT; Sinai WJ; Carr LJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1511-4. PubMed ID: 1882883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of nizatidine in commonly used intravenous fluids and containers.
    Raineri DL; Cwik MJ; Rodvold KA; Deyo KL; Scaros LP; Fischer JH
    Am J Hosp Pharm; 1988 Jul; 45(7):1523-9. PubMed ID: 3137816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of esmolol hydrochloride in intravenous solutions.
    Baaske DM; Dykstra SD; Wagenknecht DM; Karnatz NN
    Am J Hosp Pharm; 1994 Nov; 51(21):2693-6. PubMed ID: 7856582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1984 Apr; 41(4):686-9. PubMed ID: 6720710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
    Belliveau PP; Shea BF; Scavone JM
    Am J Hosp Pharm; 1993 May; 50(5):950-2. PubMed ID: 8506875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.